CMPI Report: Principles for Patient-Centered Prescription Drug Coverage

N/A by N/A is licensed under N/A N/A

Read the Report here.


Principles for Patient-Centered Prescription Drug Coverage

Monday, September 11, 2017  
8:30am – 1:30 pm
National Press Club
Holeman Lounge
529 14th St NW
Washington, DC 20045
 
Panel One:     How PBMs Affect Access and Affordability
 
Moderator:     Peter J. Pitts, President, CMPI
Panelists:         B. Douglas Hoey, CEO, National Community Pharmacists Association
                          Nick Ferreyros, Director of Communications, Community Oncology Alliance
                          Derek Daggett, Senior Business Development Executive, SmithRx

Watch Panel One highlights here.

Keynote Speaker: A. Mark Fendrick, M.D., Director, Center for Value Based Insurance Design, University of Michigan
Introduction by Robert M. Goldberg, CMPI

Watch Dr. A. Mark Fendrick's Keynote Remarks here.

Panel Two:     Principles for PBM Reform and Patient-Centered Prescription Drug Benefits
 
Moderator:   Robert M. Goldberg, PhD, Vice President, CMPI
Panelists:       Shawn Lovering, President, RxTE
                        Susan Pilch, Vice President, Policy & Regulatory Affairs, NCPA
                        A. Mark Fendrick, M.D., University of Michigan
                        Burt Zweigenhaft, Managing Partner, Upstream Partners
 
Watch Panel Two highlights here.
Article Photo Credit: N/A by N/A is licensed under N/A N/A
Sign Up for Our Email Newsletter

RECENT NEWS

Pfizer eyes FDA emergency approval for vaccine by this month

Pfizer eyes FDA emergency approval for vaccine by this month

Former U.S. FDA Associate Commissioner Peter Pitts discusses Pfizer COVID vaccine ...  Read more

Why Pfizer's COVID-19 Vaccine Trial Is Being Called a ‘Game-Changer' for the Pandemic

Why Pfizer's COVID-19 Vaccine Trial Is Being Called a ‘Game-Changer' for the Pandemic

Pfizer has released early data that shows its COVID-19 vaccine is more than 90% effective. Former FDA Associate Commissio...  Read more

World Health Organization: 70 COVID-19 Vaccines Under Development, With 3 In Human Trials

World Health Organization: 70 COVID-19 Vaccines Under Development, With 3 In Human Trials

Peter Pitts on Fox News Channel with Neil Cavuto "World Health Organization: 70 COVID-19 Vaccines Under Development, Wi...  Read more

DRUGWONKS BLOG